2013
DOI: 10.1016/j.taap.2013.06.026
|View full text |Cite
|
Sign up to set email alerts
|

System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses

Abstract: The fibrous shape and biopersistence of multi-walled carbon nanotubes (MWCNT) have raised concern over their potential toxicity after pulmonary exposure. As in vivo exposure to MWCNT produced a transient inflammatory and progressive fibrotic response, this study sought to identify significant biological processes associated with lung inflammation and fibrosis pathology data, based upon whole genome mRNA expression, bronchoaveolar lavage scores, and morphometric analysis from C57BL/6J mice exposed by pharyngeal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
46
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 52 publications
(49 citation statements)
references
References 39 publications
(69 reference statements)
3
46
0
Order By: Relevance
“…Fibrosis is a well-established endpoint in MWCNT-induced toxicity (Aiso et al, 2010;Mercer et al, 2011;Muller et al, 2005;Porter et al, 2010;Snyder-Talkington et al, 2013). In the present study, fibrosis (hepatic fibrosis/hepatic stellate cell activation) was observed as the top pathway hit following exposure to both CNT Small and CNT Large .…”
Section: Fibrosis Gene Signaturementioning
confidence: 52%
See 2 more Smart Citations
“…Fibrosis is a well-established endpoint in MWCNT-induced toxicity (Aiso et al, 2010;Mercer et al, 2011;Muller et al, 2005;Porter et al, 2010;Snyder-Talkington et al, 2013). In the present study, fibrosis (hepatic fibrosis/hepatic stellate cell activation) was observed as the top pathway hit following exposure to both CNT Small and CNT Large .…”
Section: Fibrosis Gene Signaturementioning
confidence: 52%
“…Erdely et al reported workplace exposure levels up to 10.6 μg/ m 3 , resulting in a calculated deposited dose of approximately 4.07 μg/ day in a human, equivalent to 2 ng/day in the mouse (Erdely et al, 2013). Thus, although within dose ranges of other instillation/aspiration studies (Park et al, 2009;Porter et al, 2010;Shvedova et al, 2008;Snyder-Talkington et al, 2013), the doses used in present study are to be considered high in a workplace environment.…”
Section: Dose Selectionmentioning
confidence: 72%
See 1 more Smart Citation
“…Fibrosis as an endpoint of exposure to MWCNTs and changes in gene expression have been reported in the lungs (Snyder-Talkington et al, 2013;Dong et al, 2015;Poulsen et al, 2015). Several interleukins were upregulated in WT mice.…”
Section: Discussionmentioning
confidence: 99%
“…This dose of MWCNT was based on exposures used on other studies. [28][29][30] Lungs were collected 24 h later and processed for mRNA isolation. In lungs from unchallenged wild-type mice (ie, no MWCNTs, no DM alone), we detected a Ct range for Mmp10 mRNA between 36 and 37 indicating essentially no or very low levels of expression.…”
Section: Mwcnt-induced Expression Of Mmp-10mentioning
confidence: 99%